ADMA Biologics (ADMA)
US Market

ADMA Biologics (ADMA) Stock Price & Analysis


ADMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.41 - $4.65
Previous Close$3.58
Average Volume (3M)2.09M
Market Cap
Enterprise Value$894.17M
Total Cash (Recent Filing)$62.51M
Total Debt (Recent Filing)$151.51M
Price to Earnings (P/E)-18.3
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding224,906,426
10 Day Avg. Volume1,397,601
30 Day Avg. Volume2,093,905
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)5.58
Price to Sales (P/S)13.39
Price to Cash Flow (P/CF)-32.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.30
Enterprise Value/Gross Profit25.36
Enterprise Value/Ebitda-64.02
Price Target Upside67.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was ADMA Biologics’s price range in the past 12 months?
ADMA Biologics lowest stock price was $2.41 and its highest was $4.65 in the past 12 months.
    What is ADMA Biologics’s market cap?
    Currently, no data Available
    When is ADMA Biologics’s upcoming earnings report date?
    ADMA Biologics’s upcoming earnings report date is Nov 08, 2023 which is in 38 days.
      How were ADMA Biologics’s earnings last quarter?
      ADMA Biologics released its earnings results on Aug 09, 2023. The company reported -$0.018 earnings per share for the quarter, beating the consensus estimate of -$0.025 by $0.007.
        Is ADMA Biologics overvalued?
        According to Wall Street analysts ADMA Biologics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ADMA Biologics pay dividends?
          ADMA Biologics does not currently pay dividends.
          What is ADMA Biologics’s EPS estimate?
          ADMA Biologics’s EPS estimate is >-$0.01.
            How many shares outstanding does ADMA Biologics have?
            ADMA Biologics has 224,906,430 shares outstanding.
              What happened to ADMA Biologics’s price movement after its last earnings report?
              ADMA Biologics reported an EPS of -$0.018 in its last earnings report, beating expectations of -$0.025. Following the earnings report the stock price went up 6.158%.
                Which hedge fund is a major shareholder of ADMA Biologics?
                Currently, no hedge funds are holding shares in ADMA


                ADMA Biologics Stock Smart Score

                The ADMA Biologics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                ADMA Biologics

                ADMA Biologics, Inc. operates as a biopharmaceutical company. It develops, manufactures, and intends to commercialize in human plasma and plasma-derived therapeutics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.


                Top 5 ETFs holding ADMA

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                Vanguard U.S. Momentum Factor ETF
                Schwab U.S. Broad Market ETF
                iShares Russell 3000 ETF
                Vanguard Russell 3000 ETF
                Up to five ETFs with an Outperform Smart Score that hold ADMA. The ETFs are listed according to market value of ADMA within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                DMK Pharmaceuticals
                Adverum Biotechnologies
                CymaBay Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis